Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals

CompletedOBSERVATIONAL

Enrollment

373

Participants

Timeline

Start Date

April 19, 2021

Primary Completion Date

January 20, 2023

Study Completion Date

January 20, 2023

Conditions

Covid19Immunosuppression

Interventions

DIAGNOSTIC_TEST

Blood sample

Serology, immune status, T cell immunity, and T cell aging.

DIAGNOSTIC_TEST

Saliva sample

Antibody tests

Trial Locations (1)

Medical University of Graz, Graz

All Listed Sponsors

lead

Medical University of Graz

OTHER